News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Daily News Reduced EF Evident in Some Elite Endurance Athletes Michael O'Riordan December 21, 2023
News Daily News Myocarditis Risk Low Overall After COVID-19 Vax, but Higher in Some Groups Todd Neale August 23, 2022
News Daily News Myocarditis Phenotype Is a Key Predictor of Outcomes in COVID-19 Michael O'Riordan July 20, 2022
News Daily News CVD Hospitalizations Spiked in Aftermath of 2020 US Election Michael O'Riordan April 22, 2022
News Daily News Skipping Second Dose of mRNA COVID-19 Vaccine May Limit Myocarditis in Adolescents Todd Neale February 25, 2022
News Conference News Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward Todd Neale November 16, 2021
News Daily News Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns Shelley Wood July 20, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2021 Shelley Wood May 31, 2021
News Conference News AHA 2020 INVESTED: No Added CV Benefit From High-Dose Flu Vaccine Todd Neale November 17, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2020 Shelley Wood July 31, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2020 Shelley Wood June 04, 2020
News Daily News Latest Kawasaki Series Offers Clues to COVID-19 in Kids as Debate Persists Shelley Wood May 14, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2020 Shelley Wood May 01, 2020
News Conference News AHA 2018 Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs Yael L. Maxwell November 12, 2018
News Industry News NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin® April 20, 2016